The World’s First Fully Implantable Renal Assist Device
Safe by Design • Pragmatic Disruption • 24/7 Filtration
Renalyte is transforming the $100B global dialysis market with a Safe-by-Design,
venous-only internal filtration platform.
Replacing episodic, clinic-bound dialysis with continuous, autonomous filtration 24/7
The Dialysis Paradox
Core technology hasn't changed in decades
A massive $100B+ annual global expenditure, Including a $40B+ annual burden on US Medicare alone
Lifesaving survival.
Life-limiting dependency
Surviving Isn't the Same as Living
For millions of End Stage Renal Disease (ESRD) patients, survival comes at a staggering personal cost
This is "Our Why" at Renalyte
we believe that life-saving treatment shouldn't mean life-limiting dependency.
It’s time to break the cycle and restore the freedom to truly live
The current reality of dialysis is a life measured in sessions, not moments, spending at least 156 days every year tethered to a clinic-based machine.
This isn't just a medical routine; it is a social and professional exile
Patients endure a relentless 'Yo-Yo Effect': a demanding physiological and mental cycle of rapid shifts that leaves the body in a state of chronic exhaustion.
Living from session to session, their world is is defined by the length of a tube and rigid clinic schedule
The Solution: Pragmatic Disruption
Fully Implantable system: Designed to minimize clinical risks and maximize patient mobility
Continuous Filtration: Mimicking natural biology with 24/7 fluid removal
Outpatient Maintenance: Designed for the modern healthcare ecosystem with simplified follow-up
Renalyte: The "Artificial Heart" moment for the Kidney
Safe-by-Design:
Renalyte’s Venous-only approach ensures surgical safety and long-term patency
Life, Unplugged.
Catalyzed by the US federal mandate to decentralize kidney care,
Renalyte is the safe-by-design, implantable answer to a $40B US healthcare crisis
Catalyzed by the US federal mandate to decentralize kidney care,
Renalyte is the safe-by-design, implantable answer to a $40B US healthcare crisis
Leadership Team
Leadership Team
CEO, Co-Founder
Nava Barit Ben David
An execution powerhouse with extensive leadership at J&J and AbbVie, scaling disruptive MedTech through 8200-honed analytical precision and proven market-access mastery
Leadership Team
Dr. Ehud Jacobzon, MD
CSO & Co-founder
A veteran Cardiac Surgeon and Emory-trained expert in mechanical circulatory support, translating high-stakes surgical reality into Renalyte's
Safe-by-Design renal platform
Strategic Advisory Board
A Moat of Expertise.
Our leadership is backed by an elite circle of advisors specializing in Deep-Tech hardware scaling, Clinical Nephrology leadership (MD-PhD), and Institutional Validation from world-renowned medical center
Nava Barit Ben David
CEO, Co-Founder
An execution powerhouse with extensive leadership at J&J and AbbVie, scaling disruptive MedTech through 8200-honed analytical precision and proven market-access mastery
Dr. Ehud Jacobzon, MD
A veteran Cardiac Surgeon and Emory-trained expert in mechanical circulatory support, translating high-stakes surgical reality into Renalyte's
Safe-by-Design renal platform
CSO, Co-founder